文献速递眼底病与葡萄膜炎

血管样条纹并发脉络膜新生血管的长期预后

LONG-TERM PROGNOSIS OF CHOROIDAL NEOVASCULARIZATION COMPLICATING ANGIOID STREAKS.
PubMed 文献 · Retina · 2023-01-01

这项回顾性单中心研究分析了23例患者33只眼在抗血管内皮生长因子时代血管样条纹并发脉络膜新生血管的长期视力预后。平均随访109±42个月,最佳矫正视力从首次注射时的66±19个早期治疗糖尿病视网膜病变研究字母显著下降至随访结束时的52±23个字母。中心视网膜色素上皮萎缩扩大比例在PXE组为201%、无PXE组为110%、PDT组为240%、无PDT组为111%。

要点

  • 尽管使用抗血管内皮生长因子药物,血管样条纹并发脉络膜新生血管的极长期预后相对较差
  • 最佳矫正视力从首次注射时66±19个字母下降至随访结束时52±23个字母
  • 作者认为在血管样条纹眼脉络膜新生血管管理中应谨慎使用光动力疗法

核心结论

  • 尽管使用抗血管内皮生长因子药物,极长期预后相对较差,尤其是假性黄色瘤弹性纤维瘤(PXE)患者。
  • 本研究提示在血管样条纹眼脉络膜新生血管的管理中应谨慎使用光动力疗法(PDT)。

研究设计与样本

  • 回顾性单中心研究,纳入23例患者的33只眼,分析人口统计学、脉络膜新生血管特征、血管样条纹相关疾病及既往和当前治疗。
  • 主要结局指标为通过比较谱域光学相干断层扫描自动红外图像上受累像素比例定量测量中心视网膜色素上皮萎缩扩大,以及最佳矫正视力变化。
  • 次要结局指标为玻璃体腔内注射次数及中心脉络膜厚度和中心视网膜厚度变化。
  • 亚组分析比较有或无证实PXE(「PXE」或「无PXE」)以及既往接受或未接受PDT(「PDT」或「无PDT」)眼之间的黄斑萎缩范围。

主要发现

  • 平均最佳矫正视力从首次抗血管内皮生长因子注射时的66±19个早期治疗糖尿病视网膜病变研究字母显著下降至随访结束时的52±23个字母(平均随访109±42个月,范围47-175个月)。
  • 中心视网膜色素上皮萎缩扩大比例在PXE组为201%、无PXE组为110%、PDT组为240%、无PDT组为111%。

临床怎么用

  • 作者认为在血管样条纹眼脉络膜新生血管的管理中应谨慎使用光动力疗法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report the very long-term visual prognosis of choroidal neovascularization complicating angioid streaks in the antivascular endothelial growth factor era. METHODS: Retrospective monocentric study aimed at analyzing patients' demographics, choroidal neovascularization features, angioid streak-associated conditions, and previous and current therapies for choroidal neovascularization. The main outcome measures were the quantitative measurement of central retinal pigment epithelial atrophy enlargement by comparing the ratio of pixels involved on automated infrared images acquired by spectral-domain optical coherence tomography and the changes in best-corrected visual acuity. The secondary outcome measures were the number of intravitreal injections and the changes in central choroidal thickness and central retinal thickness. Subgroup analyzes were performed to compare macular atrophy extent between eyes of patients with or without proven pseudoxanthoma elasticum ("PXE" or "no PXE") and between eyes previously treated or not with photodynamic therapy ("PDT" or "no PDT"). RESULTS: Thirty-three eyes of 23 patients were included. The mean best-corrected visual acuity decreased significantly from 66 ± 19 Early Treatment Diabetic Retinopathy Study letters at the time of the first antivascular endothelial growth factor injection to 52 ± 23 Early Treatment Diabetic Retinopathy Study letters at the end of the follow-up (mean follow-up duration: 109 ± 42 months, range: 47-175 months). The ratio of central retinal pigment epithelial atrophy enlargement was 201%, 110%, 240%, and 111% in the PXE, no PXE, PDT, and no PDT groups, respectively. CONCLUSION: Despite the use of antivascular endothelial growth factor agents, the very long-term prognosis appeared relatively poor, especially in patients with PXE. This study also suggests that PDT should be used with caution in the management of choroidal neovascularization in eyes with angioid streaks.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Rohart C, Le HM, Estrada-Walker J, et al. LONG-TERM PROGNOSIS OF CHOROIDAL NEOVASCULARIZATION COMPLICATING ANGIOID STREAKS. Retina. 2023. PMID: 36727798. doi:10.1097/IAE.0000000000003746

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。